We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

55 hedge funds and large institutions have $14.7M invested in Precision BioSciences in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 8

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

8% more funds holding

Funds holding: 51 → 55 (+4)

4.61% more ownership

Funds ownership: 45.97% → 50.58% (+4.6%)

51% less capital invested

Capital invested by funds: $29.8M → $14.7M (-$15.1M)

Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
18
Reduced
8
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Lynx1 Capital Management
Puerto Rico
+$5.59M
2
Goldman Sachs
Goldman Sachs
New York
+$2.09M
3
ACM
Aquilo Capital Management
California
+$1.13M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$719K
5
UBS Group
UBS Group
Switzerland
+$487K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.32M
2
PA
Perceptive Advisors
New York
-$3.82M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$558K
4
Stifel Financial
Stifel Financial
Missouri
-$191K
5
BOCH
Blue Owl Capital Holdings
New York
-$181K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$48K +$92.7K +12,693 New
Morgan Stanley
27
Morgan Stanley
New York
$29.6K -$20.2K -2,760 -26%
AF
28
Allworth Financial
California
$23.7K – – –
VC
29
Vivo Capital
California
$17.8K – – –
TRCT
30
Tower Research Capital (TRC)
New York
$16.4K +$28K +3,839 +819%
National Bank of Canada
31
National Bank of Canada
Quebec, Canada
$15.2K +$29.2K +4,000 New
Barclays
32
Barclays
United Kingdom
$10.9K – – –
NFSG
33
Newbridge Financial Services Group
Florida
$6.1K +$11.7K +1,600 New
Osaic Holdings
34
Osaic Holdings
Arizona
$4.84K -$7.92K -1,085 -46%
Carson Wealth (CWM LLC)
35
Carson Wealth (CWM LLC)
Nebraska
$4K +$7.34K +1,005 New
Fidelity Investments
36
Fidelity Investments
Massachusetts
$2.67K +$4.2K +575 +460%
SS
37
SBI Securities
Japan
$1.7K +$3.25K +445 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$1.05K – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$579 – – –
SC
40
SouthState Corp
Florida
$362 – – –
Zurich Cantonal Bank
41
Zurich Cantonal Bank
Switzerland
$263 -$1.38K -189 -73%
Wells Fargo
42
Wells Fargo
California
$133 -$2.19K -300 -90%
AWM
43
Ameliora Wealth Management
Switzerland
$126 – – –
NA
44
NewEdge Advisors
Louisiana
$83 – – –
Corient Private Wealth
45
Corient Private Wealth
Florida
$77 +$47K +6,431 +47%
Citigroup
46
Citigroup
New York
$50 +$88 +12 +1,200%
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$46 – – –
IRC
48
Investors Research Corp
Georgia
$30 – – –
JP Morgan Chase
49
JP Morgan Chase
New York
$30 – – –
MCM
50
MAI Capital Management
Ohio
$27 +$51 +7 New
1
2
3

DTIL Hedge Fund Activity: Q4 2024 in Review

55 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2024, worth a combined $14.7M — down 51% from $29.8M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new DTIL positions and 10 closed out — a net gain of 4 holders — while 18 added to existing stakes and 8 trimmed.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $5.59M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $6.32M sold.

  • 55 institutional investors held Precision BioSciences (DTIL) as of Q4 2024, up from 51 in Q3 2024.
  • Funds reported $14.7M of Precision BioSciences stock for Q4 2024, down 51% quarter-over-quarter.
  • 14 funds opened new Precision BioSciences positions in Q4 2024 and 10 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q4 2024 was Lynx1 Capital Management, an estimated $5.59M added.
  • The largest Precision BioSciences seller in Q4 2024 was Janus Henderson Group, an estimated $6.32M sold.

Based on aggregated 13F filings for Q4 2024.